Cargando…

Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study

BACKGROUND: The absence of nocturnal blood pressure dipping (ND) identified by 24-h ambulatory blood pressure monitoring (ABPM) correlates with a worse cardiovascular prognosis. The renin–angiotensin system influences blood pressure levels and the occurrence of target organ damage (TOD). Thus, the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cosenso-Martin, Luciana Neves, Vaz-de-Melo, Renan Oliveira, Pereira, Luana Rocco, Cesarino, Cláudia Bernardi, Yugar-Toledo, Juan Carlos, Cipullo, José Paulo, de Souza Pinhel, Marcela Augusta, Souza, Dorotéia Rossi Silva, Vilela-Martin, José Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559372/ https://www.ncbi.nlm.nih.gov/pubmed/26336879 http://dx.doi.org/10.1186/s40001-015-0166-9

Ejemplares similares

Influence of Apolipoprotein E on the Lipid Profile and Postprandial Triglyceride Levels in Brazilian Postmenopausal Women With Artery Disease
por: Tácito, Lúcia Helena Bonalume, et al.
Publicado: (2017)

Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2015)

Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population
por: Moreira, Gisela Cipullo, et al.
Publicado: (2014)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
por: Vaz-de-Melo, Renan Oliveira, et al.
Publicado: (2014)

Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016)

Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis
por: Andrade, Days O., et al.
Publicado: (2022)

Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
por: Cestario, Elizabeth do Espirito Santo, et al.
Publicado: (2022)

Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial
por: Vilela-Martin, José Fernando, et al.
Publicado: (2016)

Predictive Factors for Target Organ Injuries in Hypertensive Individuals
por: Paz Landim, Manoel, et al.
Publicado: (2021)

Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
por: Zanatta, João Marcos de Menezes, et al.
Publicado: (2021)

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
por: Cestário, Elizabeth do Espirito Santo, et al.
Publicado: (2018)

Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2020)

Oxidative stress and antioxidant status in beta-thalassemia heterozygotes
por: Ondei, Luciana de Souza, et al.
Publicado: (2013)

DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2015)

SAT-141 Effect of Vildagliptin versus Glibenclamide on Glycemic Variability and Endothelial Function in Individuals with Type 2 Diabetes and Hypertension: A Randomized Controlled Trial
por: Cosenso-Martin, Luciana, et al.
Publicado: (2019)

The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
por: Giollo-Junior, Luiz Tadeu, et al.
Publicado: (2023)

The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2019)

Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy
por: Feng, Yumei, et al.
Publicado: (2012)

The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes
por: Yugar, Louise Buonalumi Tacito, et al.
Publicado: (2023)

Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors
por: Jaleta, Gari Negeri, et al.
Publicado: (2014)

Angiotensin‐Converting Enzyme 3 (ACE3) Protects Against Pressure Overload‐Induced Cardiac Hypertrophy
por: Yu, Chang‐Jiang, et al.
Publicado: (2016)

Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy
por: A. Romero, Cesar, et al.
Publicado: (2021)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Angiotensin-Converting Enzyme Related-Polymorphisms on Inflammation, Muscle and Myocardial Damage After a Marathon Race
por: Sierra, Ana Paula Rennó, et al.
Publicado: (2019)

Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008)

LRRK2 p.G2019S Mutation Is Not Common among Alzheimer’s Disease Patients in Brazil
por: Santos-Rebouças, Cíntia Barros, et al.
Publicado: (2009)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Differential Expression of MMP2 and TIMP2 in Peripheral Blood Mononuclear Cells After Roux-en-Y Gastric Bypass
por: Nonino, Carla Barbosa, et al.
Publicado: (2021)

Treatment of hypertension with angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross‐sectional study
por: Pedrianes‐Martin, Pablo B., et al.
Publicado: (2021)

Regulation of Cardiovascular Control Mechanisms by Angiotensin-(1–7) and Angiotensin-Converting Enzyme 2
por: Ferrario, Carlos M., et al.
Publicado: (2010)

Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
por: Caldeira, Daniel, et al.
Publicado: (2012)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
por: Cotrin, Juliana Cordovil, et al.
Publicado: (2022)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Efficacy of the argon plasma coagulation in patients with weight regain after gastric bypass: a randomized control trial
por: Gurian, Gustavo Carvalho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sb6otbrrirqq4gvsvk2qt5rr9v